UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 42.529

Sortiert nach

Prognosis of Mucosal, Uveal, Acral, Nonacral Cutaneous, and Unknown Primary Melanoma From the Time of First Metastasis

The oncologist (Dayton, Ohio), 2016-07, Vol.21 (7), p.848-854

2016

Link zum Volltext

Verfügbarkeit prüfen

The World of Melanoma: Epidemiologic, Genetic, and Anatomic Differences of Melanoma Across the Globe

Current oncology reports, 2018-11, Vol.20 (11), p.87-9, Article 87

2018

Link zum Volltext

Verfügbarkeit prüfen

Cutaneous Melanoma-A Review in Detection, Staging, and Management

Hematology/oncology clinics of North America, 2019-02, Vol.33 (1), p.25

2019

Link zum Volltext

Verfügbarkeit prüfen

Uveal melanoma: From diagnosis to treatment and the science in between

Cancer, 2016-08, Vol.122 (15), p.2299-2312

2016

Link zum Volltext

Verfügbarkeit prüfen

Melanoma antigens and related immunological markers

Critical reviews in oncology/hematology, 2017-07, Vol.115, p.36-49

2017

Link zum Volltext

Verfügbarkeit prüfen

Current state of melanoma diagnosis and treatment

Cancer biology & therapy, 2019-11, Vol.20 (11), p.1366-1379

2019

Link zum Volltext

Verfügbarkeit prüfen

Cutaneous melanoma: From pathogenesis to therapy (Review)

International journal of oncology, 2018-04, Vol.52 (4), p.1071-1080

2018

Link zum Volltext

Verfügbarkeit prüfen

Adjuvant Dabrafenib plus Trametinib in Stage III BRAF-Mutated Melanoma

The New England journal of medicine, 2017-11, Vol.377 (19), p.1813-1823

2017

Link zum Volltext

Verfügbarkeit prüfen

Melanoma treatment: from conventional to nanotechnology

Journal of cancer research and clinical oncology, 2018-12, Vol.144 (12), p.2283-2302

2018

Link zum Volltext

Verfügbarkeit prüfen

Glucose transporter isoform 1 expression enhances metastasis of malignant melanoma cells

Oncotarget, 2015-10, Vol.6 (32), p.32748-32760

2015

Link zum Volltext

Verfügbarkeit prüfen

Baseline gut microbiota predicts clinical response and colitis in metastatic melanoma patients treated with ipilimumab

Annals of oncology, 2017-06, Vol.28 (6), p.1368-1379

2017

Link zum Volltext

Verfügbarkeit prüfen

A pilot trial using lymphocytes genetically engineered with an NY-ESO-1-reactive T-cell receptor: long-term follow-up and correlates with response

Clinical cancer research, 2015-03, Vol.21 (5), p.1019-1027

2015

Link zum Volltext

Verfügbarkeit prüfen

Epidemiology and survival outcomes of ocular and mucosal melanomas: A population‐based analysis

International journal of cancer, 2014-06, Vol.134 (12), p.2961-2971

2014

Link zum Volltext

Verfügbarkeit prüfen

Emerging strategies to treat rare and intractable subtypes of melanoma

Pigment cell and melanoma research, 2021-01, Vol.34 (1), p.44-58

2021

Link zum Volltext

Verfügbarkeit prüfen

Cutaneous melanoma: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up

Annals of oncology, 2015-09, Vol.26, p.v126-v132

2015

Link zum Volltext

Verfügbarkeit prüfen

Multi-stage Differentiation Defines Melanoma Subtypes with Differential Vulnerability to Drug-Induced Iron-Dependent Oxidative Stress

Cancer cell, 2018-05, Vol.33 (5), p.890-904.e5

2018

Link zum Volltext

Verfügbarkeit prüfen

Immunotherapy for the Treatment of Uveal Melanoma: Current Status and Emerging Therapies

Current oncology reports, 2017-07, Vol.19 (7), p.45-45, Article 45

2017

Link zum Volltext

Verfügbarkeit prüfen

Molecular Pathways in Melanomagenesis: What We Learned from Next-Generation Sequencing Approaches

Current oncology reports, 2018-11, Vol.20 (11), p.86-16, Article 86

2018

Link zum Volltext

Verfügbarkeit prüfen

Tumor Mutational Burden as an Independent Predictor of Response to Immunotherapy in Diverse Cancers

Molecular cancer therapeutics, 2017-11, Vol.16 (11), p.2598-2608

2017

Link zum Volltext

Verfügbarkeit prüfen

Connecting the dots: Melanoma cell of origin, tumor cell plasticity, trans‐differentiation, and drug resistance

Pigment cell and melanoma research, 2023-09, Vol.36 (5), p.330-347

2023

Link zum Volltext

Verfügbarkeit prüfen

Neurologic Serious Adverse Events Associated with Nivolumab Plus Ipilimumab or Nivolumab Alone in Advanced Melanoma, Including a Case Series of Encephalitis

The oncologist (Dayton, Ohio), 2017-06, Vol.22 (6), p.709-718

2017

Link zum Volltext

Verfügbarkeit prüfen

Mucosal melanomas of different anatomic sites share a common global DNA methylation profile with cutaneous melanoma but show location‐dependent patterns of genetic and epigenetic alterations

The Journal of pathology, 2022-01, Vol.256 (1), p.61-70

2022

Link zum Volltext

Verfügbarkeit prüfen

Impact of Age on Outcomes with Immunotherapy for Patients with Melanoma

The oncologist (Dayton, Ohio), 2017-08, Vol.22 (8), p.963-971

2017

Link zum Volltext

Verfügbarkeit prüfen

1 – 25 von 42.529

Suche als RSS-Feed

Aktive Filter

ThemaOncology

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(37.843)
Mit Volltextzugriff
(36.994)

Publikationsform

3 weitere anzeigen...

Weniger anzeigen...

Sprache

10 weitere anzeigen...

Weniger anzeigen...

Erscheinungsjahr

n.n

Thema

Science & Technology
(39.700)
Life Sciences & Biomedicine
(39.247)
Humans
(28.375)
Melanoma
(25.545)
Female
(13.631)
Male
(11.993)
Tumors
(11.786)
Melanoma - Pathology
(10.444)
Animals
(9.290)
Middle Aged
(9.240)
Biological And Medical Sciences
(8.762)
Medical Sciences
(8.441)
Metastasis
(8.338)
Immunotherapy
(8.203)
Cancer
(7.707)
Aged
(7.657)
Adult
(7.652)
Mice
(7.233)
Dermatology
(7.126)

14 weitere anzeigen...

Weniger anzeigen...

Kollektion

Elektronische Zeitschriftenbibliothek (Open access)
(23.920)
Ingenta
(18.013)
Journals@Ovid Complete
(17.580)
IngentaConnect Journals
(11.494)
SpringerLink (Online service)
(7.616)
Single Journals
(7.556)
Wiley Online Library - AutoHoldings Journals
(6.006)
SpringerLINK Contemporary (Konsortium Baden-Württemberg)
(4.732)
Wiley Online Library Full Collection 2018
(4.619)
Elsevier ScienceDirect Journals Complete
(4.478)
Nexis Uni
(3.130)
Elsevier Journal Backfiles on ScienceDirect (DFG Nationallizenzen)
(2.953)
Nature
(2.192)
SpringerLink Series
(1.398)
Taylor & Francis
(1.089)
BMJ Journals
(1.061)
Taylor & Francis Journals Complete
(920)
Oxford Journals Online Current
(787)
Oxford Journals 2020 Medicine
(729)
Factiva
(705)

15 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

Cancer Research
(2.126)
Melanoma Research
(2.117)
Cancers
(1.898)
International Journal Of Cancer
(1.337)
Cancer
(1.292)
Annals Of Surgical Oncology
(1.014)
Cancer Immunology Immunotherapy
(949)
British Journal Of Cancer
(920)
Journal For Immunotherapy Of Cancer
(904)
Clinical Cancer Research
(896)

5 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

Menü

Weitere Dienste

Einstellungen

Prognosis of Mucosal, Uveal, Acral, Nonacral Cutaneous, and Unknown Primary Melanoma From the Time of First Metastasis

The World of Melanoma: Epidemiologic, Genetic, and Anatomic Differences of Melanoma Across the Globe

Cutaneous Melanoma-A Review in Detection, Staging, and Management

Uveal melanoma: From diagnosis to treatment and the science in between

Melanoma antigens and related immunological markers

Current state of melanoma diagnosis and treatment

Cutaneous melanoma: From pathogenesis to therapy (Review)

Adjuvant Dabrafenib plus Trametinib in Stage III BRAF-Mutated Melanoma

Melanoma treatment: from conventional to nanotechnology

Glucose transporter isoform 1 expression enhances metastasis of malignant melanoma cells

Baseline gut microbiota predicts clinical response and colitis in metastatic melanoma patients treated with ipilimumab

A pilot trial using lymphocytes genetically engineered with an NY-ESO-1-reactive T-cell receptor: long-term follow-up and correlates with response

Codon-specific translation reprogramming promotes resistance to targeted therapy

Epidemiology and survival outcomes of ocular and mucosal melanomas: A population‐based analysis

Emerging strategies to treat rare and intractable subtypes of melanoma

European consensus-based interdisciplinary guideline for melanoma. Part 1: Diagnostics: Update 2022

Cutaneous melanoma: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up

Multi-stage Differentiation Defines Melanoma Subtypes with Differential Vulnerability to Drug-Induced Iron-Dependent Oxidative Stress

Immunotherapy for the Treatment of Uveal Melanoma: Current Status and Emerging Therapies

Molecular Pathways in Melanomagenesis: What We Learned from Next-Generation Sequencing Approaches

Tumor Mutational Burden as an Independent Predictor of Response to Immunotherapy in Diverse Cancers

Connecting the dots: Melanoma cell of origin, tumor cell plasticity, trans‐differentiation, and drug resistance

Neurologic Serious Adverse Events Associated with Nivolumab Plus Ipilimumab or Nivolumab Alone in Advanced Melanoma, Including a Case Series of Encephalitis

Mucosal melanomas of different anatomic sites share a common global DNA methylation profile with cutaneous melanoma but show location‐dependent patterns of genetic and epigenetic alterations

Impact of Age on Outcomes with Immunotherapy for Patients with Melanoma

Aktive Filter

Suchergebnisse filtern